RhumbLine Advisers’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$325K Buy
5,716
+550
+11% +$31.3K ﹤0.01% 2937
2025
Q1
$289K Sell
5,166
-829
-14% -$46.5K ﹤0.01% 2909
2024
Q4
$369K Sell
5,995
-650
-10% -$40K ﹤0.01% 2857
2024
Q3
$445K Buy
6,645
+1,137
+21% +$76.1K ﹤0.01% 2775
2024
Q2
$368K Buy
5,508
+812
+17% +$54.2K ﹤0.01% 2874
2024
Q1
$334K Buy
4,696
+158
+3% +$11.2K ﹤0.01% 2924
2023
Q4
$382K Sell
4,538
-85
-2% -$7.16K ﹤0.01% 2821
2023
Q3
$398K Buy
4,623
+124
+3% +$10.7K ﹤0.01% 2745
2023
Q2
$419K Sell
4,499
-84
-2% -$7.83K ﹤0.01% 2806
2023
Q1
$434K Buy
4,583
+82
+2% +$7.77K ﹤0.01% 2488
2022
Q4
$452K Buy
4,501
+112
+3% +$11.2K ﹤0.01% 2514
2022
Q3
$374K Buy
4,389
+275
+7% +$23.4K ﹤0.01% 2631
2022
Q2
$353K Sell
4,114
-487
-11% -$41.8K ﹤0.01% 2671
2022
Q1
$413K Sell
4,601
-393
-8% -$35.3K ﹤0.01% 2505
2021
Q4
$499K Sell
4,994
-52
-1% -$5.2K ﹤0.01% 2511
2021
Q3
$468K Buy
5,046
+175
+4% +$16.2K ﹤0.01% 2577
2021
Q2
$414K Buy
4,871
+411
+9% +$34.9K ﹤0.01% 2649
2021
Q1
$386K Sell
4,460
-150
-3% -$13K ﹤0.01% 2605
2020
Q4
$389K Buy
4,610
+351
+8% +$29.6K ﹤0.01% 2548
2020
Q3
$340K Sell
4,259
-624
-13% -$49.8K ﹤0.01% 2459
2020
Q2
$433K Buy
4,883
+115
+2% +$10.2K ﹤0.01% 2415
2020
Q1
$448K Hold
4,768
﹤0.01% 2214
2019
Q4
$514K Buy
4,768
+35
+0.7% +$3.77K ﹤0.01% 2347
2019
Q3
$454K Buy
4,733
+68
+1% +$6.52K ﹤0.01% 2365
2019
Q2
$446K Sell
4,665
-7
-0.1% -$669 ﹤0.01% 2401
2019
Q1
$412K Buy
4,672
+31
+0.7% +$2.73K ﹤0.01% 2407
2018
Q4
$386K Buy
4,641
+1,576
+51% +$131K ﹤0.01% 2417
2018
Q3
$289K Sell
3,065
-200
-6% -$18.9K ﹤0.01% 2536
2018
Q2
$360K Buy
3,265
+136
+4% +$15K ﹤0.01% 2453
2018
Q1
$309K Sell
3,129
-80
-2% -$7.9K ﹤0.01% 2420
2017
Q4
$261K Sell
3,209
-602
-16% -$49K ﹤0.01% 2523
2017
Q3
$280K Sell
3,811
-70
-2% -$5.14K ﹤0.01% 2586
2017
Q2
$281K Sell
3,881
-425
-10% -$30.8K ﹤0.01% 2592
2017
Q1
$268K Buy
4,306
+157
+4% +$9.77K ﹤0.01% 2561
2016
Q4
$302K Sell
4,149
-546
-12% -$39.7K ﹤0.01% 2489
2016
Q3
$281K Buy
4,695
+100
+2% +$5.99K ﹤0.01% 2520
2016
Q2
$289K Buy
4,595
+621
+16% +$39.1K ﹤0.01% 2555
2016
Q1
$249K Buy
3,974
+125
+3% +$7.83K ﹤0.01% 2625
2015
Q4
$225K Buy
+3,849
New +$225K ﹤0.01% 2738
2015
Q3
Sell
-3,470
Closed -$207K 3020
2015
Q2
$207K Sell
3,470
-200
-5% -$11.9K ﹤0.01% 2874
2015
Q1
$220K Buy
+3,670
New +$220K ﹤0.01% 2781